Jeffrey Yoshida, M.D.
Urology Physician in Irvine, California. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers — including 13,350 in Urology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration — see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Jeffrey Yoshida, M.D. reported a CMS MIPS final score of 99.1/100 — above the 83.1 national average — and filed 236 Medicare Part D claims in 2023.
- 99.1/100
- MIPS score · +16 vs avg
- 236
- Part D claims, 2023
- 92%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
Jeffrey Yoshida, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
99 Top 9% higher than 91% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Jeffrey Yoshida, M.D. sits
This provider among urology physician peers
Across the 4,623 urology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Jeffrey Yoshida, M.D. writes more Part D claims than 13% of them and scores higher on MIPS quality than 87% — placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one urology physician peer from a representative sample of 60; the gold marker is Jeffrey Yoshida, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Jeffrey Yoshida, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Jeffrey Yoshida, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in California
How Urology Physician compares to other specialties among California providers
Largest specialties in California (% of in-state providers)
Urology Physician ranks #75 among California's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the California provider total, by primary NUCC taxonomy. The highlighted bar is Urology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance — MIPS
Jeffrey Yoshida, M.D.'s 2023 MIPS final score plotted against the Urology Physician national average
- MIPS Final Score
- 99.1/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Urology Physician) — 99.1/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Urology Physician US NPIs
99.1/100 MIPS final score — 16.0 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Urology Physician. Quality dim: 85.2.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Jeffrey Yoshida, M.D. appears in the CMS NPPES registry as a Urology Physician provider holding M.D. credentials at 1000 FIVEPOINT, Irvine, CA, 92618, with a listed phone of (949) 671-4673. NPI 1922106657 was issued on 09/20/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Yoshida most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 236 prescription claims written by this provider, covering 74 Medicare beneficiaries and totaling roughly $183K in drug spend, split 8% brand-name and 92% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 99.1/100 for the 2023 performance year (Quality 85.2), compared with the national average of 83.1.
Urology Physician is a mid-sized specialty nationwide, with 13,350 enrolled providers across 54 states and an average of 1,280 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1922106657 |
|---|---|
| Specialty | Urology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 09/20/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Jeffrey Yoshida, M.D.'s current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Jeffrey Yoshida, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Jeffrey Yoshida, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$4.5K
Largest payer
INTUITIVE SURGICAL, INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — California MBC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to Jeffrey Yoshida, M.D.. To verify Jeffrey Yoshida, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
8% brand-name claims vs 92% generic, on 236 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 478
- Total Day Supply
- 14,219
- Brand vs Generic
- 8% brand / 92% generic
- Brand Drug Cost
- $30K
- Generic Drug Cost
- $153K
Patient Demographics
- Average Patient Age
- 76.2 years
- Avg HCC Risk Score
- 1.12
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Jeffrey Yoshida, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Tamsulosin Hcl
Tamsulosin Hcl
59 claims
- Abiraterone Acetate
Abiraterone Acetate
32 claims
- Finasteride
Finasteride
25 claims
- Prednisone
Prednisone
25 claims
- Dutasteride 23
Dutasteride
23 claims
- Alfuzosin Hcl Er 16
Alfuzosin Hcl Er
16 claims
- Myrbetriq 15
Myrbetriq
15 claims
- Bicalutamide 12
Bicalutamide
12 claims
| Drug | Claims |
|---|---|
| Tamsulosin Hcl | 59 |
| Abiraterone Acetate | 32 |
| Finasteride | 25 |
| Prednisone | 25 |
| Dutasteride | 23 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 16 |
| Myrbetriq Mirabegron | 15 |
| Bicalutamide | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Urology Physician Overview
How Jeffrey Yoshida, M.D. fits within the Urology Physician landscape nationally.
Jeffrey Yoshida, M.D.'s 236 claims are below the specialty average of 1,280.
Nearby Urology Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Yoshida.
Compare Urology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry — providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the California medical board — federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Urology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only — they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore California
Frequently Asked Questions
What is Jeffrey Yoshida, M.D.'s specialty? ▼
How much does Jeffrey Yoshida, M.D. prescribe under Medicare Part D? ▼
What is Jeffrey Yoshida, M.D.'s Medicare quality score? ▼
Where is Jeffrey Yoshida, M.D. located? ▼
What is Jeffrey Yoshida, M.D.'s NPI number? ▼
Does Jeffrey Yoshida, M.D. prescribe more brand-name or generic drugs? ▼
How many Urology Physician providers are there in the US? ▼
What drugs does Jeffrey Yoshida, M.D. prescribe most often? ▼
Does Jeffrey Yoshida, M.D. accept Medicare? ▼
How can I verify Jeffrey Yoshida, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology